Company page

Eirgenix, Inc.

Eirgenix, Inc. is a public company listed on the Taiwan stock market under the ticker 6589. The company has a market capitalization of approximately NT$422.8 million. Eirgenix focuses on developing innovative biopharmaceuticals and aims to address unmet medical needs.